packageAsfotaseAlfa

asfotase alfa

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Asfotase alfa is an enzyme replacement therapy used to treat hypophosphatasia. It is authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q22075839 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:asfotase alfa
ATC codes:A16AB13
DrugBank:DB09105
Wikidata:Q22075839
molar mass:180000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown